Insiders | Shares | % | Avg Price | Total $ | |
---|---|---|---|---|---|
Buys | 1 | +14.5K | 100% | $1.75 | +$25.4K |
Sells | 0 | ||||
Net | +1 | +14.5K | 100% | +$25.4K |
Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
---|---|---|---|---|---|
Clarus Lifesciences III, L.P. | 10%+ Owner | $123M | May 12, 2021 | ||
Nicole Sweeny | Chief Commercial Officer | $973K | Feb 12, 2023 | ||
Jill DeSimone | Director | $365K | +$25.4K | +7.47% | Jun 5, 2024 |
Marcio Souza | Chief Executive Officer, Director | $246K | Jul 29, 2024 | ||
Timothy Edwin Kelly | Chief Financial Officer | $150K | Jul 29, 2024 | ||
Alex Nemiroff | General Counsel and Secretary | $136K | Jul 29, 2024 | ||
Lauren Mastrocola | Principal Accounting Officer | $79.5K | Jul 29, 2024 | ||
Gregory Norden | Director | Jun 5, 2024 | |||
Stefan Vitorovic | Director | May 26, 2022 | |||
William D. Young | Director | Jun 5, 2024 | |||
Bernard Ravina | Chief Medical Officer | Jun 22, 2022 | |||
Dean J. Mitchell | Director | Jun 5, 2024 | |||
BSOF Parallel Master Fund L.P. | 10%+ Owner | Oct 6, 2021 | |||
Merit Ester Cudkowicz | Director | Jun 5, 2024 | |||
Jeffrey Chodakewitz | Director | Jun 5, 2024 |
Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
---|